Abbott Laboratories' January price pullback is a signal to load up on shares; this Dividend Aristocrat is growing its ...
Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.
Pricing challenges in Abbott’s nutrition business and lower than expected sales of continuous glucose monitors drove down the company’s shares.
Abbott shares fell after quarterly sales and early 2026 earnings guidance missed estimates, even as the company forecast ...
Abbott's Medical Devices segment, especially CGM, continues to deliver robust double-digit growth, offsetting Nutrition ...
Abbott Laboratories ( ABT) Q4 2025 Earnings Call January 22, 2026 9:00 AM EST Good morning, and thank you for standing by.
Abbott Laboratories forecast a 1Q profit that was lower than Wall Street expected and missed 4Q sales estimates after its ...
Abbott shares sank 8% as Q4 revenue of $11.5B missed the $11.8B target, with nutrition sales dropping 8.9% on price ...
Medical Device Network on MSN
Abbott’s stock falls by nearly 11% following Q4 sales miss
Abbott missed analysts’ profit expectations for Q4 2025, yet the company’s full year financials were buoyed by strong ...
Abbott Laboratories (NYSE:ABT) Q4 2025 Earnings Call Transcript January 22, 2026 Abbott Laboratories reports earnings inline ...
Abbott Laboratories (NYSE:ABT) reported fourth-quarter earnings that met expectations but missed on revenue, sending shares down 4.8% as investors reacted to the shortfall and weaker-than-expected ...
Abbott forecast current-quarter profit below estimates after missing Wall Street expectations for quarterly revenue on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results